October 11, 2024

Mid-treatment PET-adapted radiotherapy dose escalation fails to improve outcomes for lung cancer patients: Results of NRG-RTOG1106/ECOG-ACRIN 6697

October 10, 2024

Women in medicine month: celebrating women advancing radiology (mentions TMIST investigator Rita Freimanis, MD)

September 26, 2024

The Fall 2024 advocacy blog Considering Clinical Trials is now available

August 29, 2024

How the CompassHER2 pCR trial (EA1181) and other novel studies seek to optimize HER2+ breast cancer management

August 21, 2024

How a patient’s role in a clinical trial for acute lymphocytic leukemia brought a cancer-free diagnosis, FDA approval

August 21, 2024

The implications of the E3311 trial in HPV+ head and neck cancer: Dr. Ranee Mehra

August 20, 2024

Blinatumomab improves 3-year overall survival in B-ALL versus chemotherapy (study E1910)

August 17, 2024

Nivolumab’s role in esophageal cancer neoadjuvant therapy: Dr. Jennifer Eads (study EA2174)

August 1, 2024

Advocate Health Care and Aurora Health Care cancer clinics join the EAQ211 trial, which seeks to determine why young lymphoma survivors are at high risk for other health problems

ECOG-ACRIN Cancer Research Group